LOXL1 and pancreatic neoplasm: Deregulation of LOXL1-AS1 has also been reported in some types of other cancer such as pancreatic cancer, osteosarcoma, medulloblastoma, choriocarcinoma, retinoblastoma, thymoma and thymic carcinoma and renal cell carcinoma (RCC) (23, 32, 98–102).